Current pharmacological treatment approaches for alcohol dependence. - Wikidata - awgldk - TriplyDB

Current pharmacological treatment approaches for alcohol dependence.

Current pharmacological treatment approaches for alcohol dependence.

http://www.wikidata.org/entity/Q38181213

about

Neurobiologic Advances from the Brain Disease Model of Addiction Translating Alcohol Research: Opportunities and Challenges Alcohol liver disease: A review of current therapeutic approaches to achieve long-term abstinence In Vitro and In Vivo Evaluations of PLGA Microspheres Containing Nalmefene Nalmefene for the treatment of alcohol use disorders: recent data and clinical potential.Varenicline in the treatment of alcohol use disorders.Topiramate: a review of analytical approaches for biological matrices.Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision.R(+)-Baclofen, but Not S(-)-Baclofen, Alters Alcohol Self-Administration in Alcohol-Preferring Rats.Gabapentin potentiates sensitivity to the interoceptive effects of alcohol and increases alcohol self-administration in rats Identification and management of alcohol withdrawal syndrome Emerging drugs for antipsychotic-induced tardive dyskinesia: investigational drugs in Phase II and Phase III clinical trials.Intrathecal Baclofen therapy in Germany: Proceedings of the IAB-Interdisciplinary Working Group for Movement Disorders Consensus Meeting.Topiramate: A Review of Analytical Approaches for the Drug Substance, Its Impurities and Pharmaceutical Formulations.Neurobiology of comorbid post-traumatic stress disorder and alcohol-use disorder.Review article: pharmacotherapy for alcohol dependence - the why, the what and the wherefore.Pharmacotherapy of alcoholism - an update on approved and off-label medications.Synergistic blockade of alcohol escalation drinking in mice by a combination of novel kappa opioid receptor agonist Mesyl Salvinorin B and naltrexone.Baclofen systemic toxicity: Experimental histopathological and biochemical study.Reduced Drinking in Alcohol Dependence Treatment, What Is the Evidence?The Multidimensional Therapeutic Potential of Targeting the Brain Oxytocin System for the Treatment of Substance Use Disorders.Baclofen and Alcohol-Dependent Patients: A Real Risk of Severe Self-Poisoning.Involvement of activated brain stress responsive systems in excessive and "relapse" alcohol drinking in rodent models: implications for therapeutics.

P2860

Q26774129-424674F6-D0B9-47B1-844E-30BF43989208 Q26799819-D57E836A-92CC-45F9-A92F-D3164D183AF2 Q26801196-D12841A7-8563-472F-9756-B70BFDB45445 Q28546982-A59A50E3-CB8F-4A41-B43B-795B2E9E2787 Q31039835-066C8A93-A320-4FD9-8D6C-2B7B16E1FD4E Q35219810-68D7AA1A-FBA1-4F37-A22E-4C00ABE2648A Q35601185-37FDC2D1-EA80-4545-B13D-7EEA1BBB02B5 Q36231851-C215C6ED-6856-47F8-9CA2-CC40E2DAF2EE Q36805735-0F714D94-17D3-4BEA-991D-9B9C34CB3FE9 Q36872261-984001D5-F989-4A68-B320-5CDE51CCFD10 Q37161994-B5FDE8E1-55C4-4C7B-8774-D7BEA25899C0 Q38545655-73B6D93E-936E-407A-9B16-AA59D670C536 Q38548063-5C0559EB-EFEB-459E-B17F-E85532843887 Q38567300-122BCB98-1A6B-481A-9661-C776BDAA3EDA Q38982604-3047C698-3DB6-4533-9217-E0BC8DB44D8D Q39144955-59FCDB96-E70D-4E91-8097-24503687EA2C Q43061723-7D183425-B60F-451B-A2CF-49228CED8254 Q44343754-2A7A0C78-5D0B-456C-950E-08C23FB24CF1 Q46737082-EC00AAEB-41AD-464A-A2C8-44C57B0A818D Q47616924-6B442443-C8DE-46CA-B40B-AFDC8A67E4CB Q47681320-9AE5860F-FDFB-4F96-B650-8C373396D8C1 Q50790059-1834D112-F835-43E2-9629-5C7391B9ECFE Q52317998-9BA40EE2-5655-446E-9D37-B7E6B00BF974

P2860

Current pharmacological treatment approaches for alcohol dependence.

http://www.wikidata.org/entity/Q38181213

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Current pharmacological treatment approaches for alcohol dependence.

@en

type

label

Current pharmacological treatment approaches for alcohol dependence.

@en

prefLabel

Current pharmacological treatment approaches for alcohol dependence.

@en

P1433

Q38181213-3A863B29-725D-483B-A4B0-F71296070CCC

P1476

Q38181213-1F910DA5-2F11-4D3B-A8DB-BCF1B031B76A

P2093

Q38181213-B174C5CA-BC83-4EE4-961C-53DE3A393AAB

Q38181213-BAE13095-9FFB-46D8-BB64-2BE3F00929EE

Q38181213-D99A0DDA-EDDE-4617-BFB0-1F81BCBAA1B1

Q38181213-F6A77385-DA8E-4262-9693-551F88CFF53C

P2860

Q38181213-01AECC7F-261A-45B8-94B7-583C3DF340FC

Q38181213-028E8F9D-44CB-4707-8C2E-2914BD5EE7E9

Q38181213-0397BEF0-4432-4AB7-ABE0-4A54BD24E9A4

Q38181213-05D3C38A-0E72-4A7F-9BF1-0EF066DA51C2

Q38181213-062E0426-B14E-4EFF-8BD0-DBC1E94E5A9C

Q38181213-1387DFCD-36C4-421C-AD78-0AF9AA4FFFDD

Q38181213-14D59363-D083-40EA-B4BE-F83A22480305

Q38181213-1EFB4583-3B65-45EC-B6FC-E85AFC21F7F0

Q38181213-20ED2F8C-1F83-4860-90D4-D9F09C260020

Q38181213-271552DA-DFF9-446C-A5BF-8092F2572277

P304

Q38181213-62237DFC-7180-46EC-93B4-34315BD4E017

P31

Q38181213-54A95520-F2F5-419C-9F1D-2D211A6C570B

P356

Q38181213-2F7AD963-CB68-42D0-902E-FAC3EE0655EF

P407

Q38181213-50702473-566C-4C4B-AFF1-DB365FD2468A

P433

Q38181213-56001CCF-66D2-49C8-AA45-C819D4172DF3

P478

Q38181213-96B1EA64-CBBB-4A44-80B7-946960E21817

P577

Q38181213-7CFEB38A-2AAC-44D7-ADFF-C2C2EC6697F0

P698

Q38181213-033B0494-AB2D-4465-ADCC-232478402BDE

P921

Q38181213-C8ACEB7E-F385-46EB-B94C-600C6573F5A3

P356

14656566.2014.876008

P1433

Expert Opinion on Pharmacotherapy

P1476

Current pharmacological treatment approaches for alcohol dependence.

@en

P2093

Andreas Heinz

http://www.w3.org/2001/XMLSchema#string

Christian A Müller

http://www.w3.org/2001/XMLSchema#string

Olga Geisel

http://www.w3.org/2001/XMLSchema#string

Roman Banas

http://www.w3.org/2001/XMLSchema#string

P2860

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity?

Acamprosate: recent findings and future research directions

Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat

Determination of genotype combinations that can predict the outcome of the treatment of alcohol dependence using the 5-HT(3) antagonist ondansetron.

A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence

A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patients

Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking.

Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function.

Topiramate for treating alcohol dependence: a randomized controlled trial.

P304

471-481

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2014.876008

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24456374

http://www.w3.org/2001/XMLSchema#string

P921